Table 1

 Demographic features in patients with SSc with disease subtype (diffuse (D) or limited (L)), presence of specific antibodies, and organ involvement

PatientsAge (years)SexDuration of disease (years)Disease subtypePeptides inducing proliferationSpecific antibodiesOrgan involvement*
Lung fibrosisOther organs
*All patients had skin and oesophageal involvement.
ARA, anti-RNA polymerase; ATA, antitopoisomerase I; Th-RNP, antiribonucleic protein; ACA, anticentromere antibody; APA, anti-PM-Scl-70; ND, none detected.
164M4DNoneARAYesMuscle
251F4DNoneATAYes
334F9LNoneATAYes
443F18L3, 4, 5, 6Th-RNPNoKidney
562M10L3, 4, 5ATAYesBowel
660F8LNoneATAYes
754F9L5ATAYes
850F5LNoneATAYes
933F19LNoneNDYes
1066F5L5NDYes
1157F16D3, 4APAYesMuscle
1257F17L3, 5, 6ACANo
1353M15D5ATAYesMuscle
1463F22LNoneARAYes
1563F3D5NDYesBowel
1656F15LNoneAPAYesHeart
1755F15L2, 3, 4, 6NDYes
1843F4LNoneNDYesKidney
1949F3LNoneNDYes
2055F2L5ATAYes
2155F6LNoneNDNoBowel